Achieving greater transparency with no transparency

This is a preview of subscriber content

Subscribe now to continue reading.

The irony is that the committee considered the public summary document issue at its intracycle meeting in May this year. It was not included on any agenda and the first anyone heard of it was through informal mentions and when the outcomes were officially published in late June - so, achieving greater transparency with no transparency. …

Subscribe now to continue reading.

Achieving greater transparency with no transparency

This is a preview of subscriber content

Latest Video

Most Read

Australia risks a two tier health system as patients take their fight to Canberra

'You can't fix a broken system by tinkering with parts of it'

Guilt over this enduring failure is the correct response

Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this

The forgotten patients living in the long shadow of rare cancer

New Stories

NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms

Rare genetic motor neurone disease treatment finally reaches Australian patients

Taking a stake is not the same as spectating investor risk and expecting a benefit

Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this

Melbourne oncologist takes the reins at Australia's private cancer physicians body

Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence

Which is it? The two perspectives on patient input compounded by the lack of transparency

Sign In

Achieving greater transparency with no transparency

This is a preview of subscriber content

Latest Video

Most Read

Australia risks a two tier health system as patients take their fight to Canberra

'You can't fix a broken system by tinkering with parts of it'

Guilt over this enduring failure is the correct response

Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this

The forgotten patients living in the long shadow of rare cancer

Follow Us

New Stories

NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms

Rare genetic motor neurone disease treatment finally reaches Australian patients

Taking a stake is not the same as spectating investor risk and expecting a benefit

Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this

Melbourne oncologist takes the reins at Australia's private cancer physicians body

Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence

Which is it? The two perspectives on patient input compounded by the lack of transparency